2 March 2023

ANCA-associated vasculitis Corticosteroids

Avacopan cuts steroid side effects in new trial analysis

2 March 2023

Anti JAKS Lupus

‘Back to the drawing board’ for JAKi in lupus

2 March 2023

Biologics Dermatology

Monoclonal antibody hope for hidradenitis suppurativa

2 March 2023

Pharmaceuticals Public Health

‘Catastrophic’: warning on antimicrobial resistance

23 February 2023

Myositis

CAR T-cell revolution hits new rheum target

23 February 2023

Pharmaceuticals Pregnancy TGA

Avoid pregabalin in pregnancy, TGA warns

23 February 2023

Mental Health

Alarming rise in female doctors’ suicide rates

23 February 2023

Pregnancy

Where do rheum patients look for pregnancy advice?

23 February 2023

Obesity

Obesity and diabetes: is air quality to blame?

23 February 2023

Obesity Pharmaceuticals Political

Who deserves Ozempic, anyway?

16 February 2023

ARA Rural

Rheumatology workforce survey report released

16 February 2023

Communicable Disease Public Health

Vigilance needed after Murray Valley encephalitis death and detection

16 February 2023

Mental Health Obesity

Suicide and liver risk after bariatric surgery

16 February 2023

Rural

Our CDC must have equity as top priority

9 February 2023

Imaging Rheumatoid Arthritis

It’s the thought that counts with T2T

9 February 2023

ANCA-associated vasculitis Pharmaceuticals TGA

Avacopan TGA approved for ANCA-associated vasculitis